Mental health problems have become increasingly prevalent among graduate students, yet they are easily overlooked. I recently read In this commentary, Shorr highlights how he unexpectedly learned that a significant number of graduate students are affected by mental health disorders and in particular, depression.
When I began my graduate journey, I wasn’t sure what my career objectives were, or how I would accomplish them. I quickly realized that it was ‘trendy’ to make assertions of how I was going to transition into industry, but that was the extent of my plan at this point. Furthermore, I thought the only possible route into industry for a Ph.D. was to be a post-doc or bench scientist for a small startup or large pharmaceutical company. Little did I know that this was just one option of many!
Me: “I’m not applying to the School of Pharmacy after I graduate. I have no idea what my plans are; I just really like research.” My mom: “WHAT?!?” The day I told my Puerto Rican parents that I was not pursuing my dream job, and that I was confused about my future career plans, I knew their hearts sank. They thought their only child was lost and this was not what they had envisioned for me. I started my B.S. in Chemistry with the intention of completing the required 80 credits to apply to the School of Pharmacy.
The following blog post was written after attending the iJOBS Career Panel: Product Development, Tech and Sales Support in Life Sciences Companies on October 3, 2017. Do you like communicating with other scientists about their projects? Do you enjoy being an expert in a particular method and explaining that method to non-experts? Do you enjoy meeting new people? Then boy, do I have a job for you! If you have overlooked sales and tech support as a job opportunity, you may be missing out on a rewarding, meaningful, fun, and interesting career choice.
This post was written following the September 28, 2017 iJOBS event with Regeneron Regeneron prides itself for being a company thriving on quality research and the active role it plays in the entire life cycle of its drugs. The company was found by two M.D Ph.Ds (Leonard S. Schleifer and George D. Yancopoulos) with the goal of creating regenerative medicine for neuroscience research. The company, which initially received $1 million in venture capital funding, now has over 5,500 employees and 6 FDA-approved drugs, which were all invented in-house, from start to finish.
This post was written after the September 27, 2017 iJOBS event: Applying for jobs as an international student, advice from an immigration attorney held at Rutgers University On September 27th, immigration lawyer Michael J. Goldstein gave a talk on the process of going from a student with F1 status to finding a job with an H1-B petition and further. During a time of turmoil regarding immigration laws, Goldstein stressed how important it is to find a lawyer focused primarily on immigration law.
In the age of venture capital funding and angel investors, the National Science Foundation NSF has created the Innovation Corps (I-corps) program to promote tech entrepreneurship. It primarily aims to increase the economic impact of academic research projects. Unfortunately, several factors can impede the process of taking scientific research from academic labs to create successful economic ventures.
Anyone who has ever spent a summer on campus knows that come July, it is swarming with running, smiling, and laughing youngsters. It is nearly impossible to walk into the Busch Campus Center without seeing someone under the age of 18.
On the evening of September 12, a casual event between students, post docs, and alumni was held in the Rutgers Robert Wood Johnson Medical School Research Tower at the Bush/Piscataway campus. As a second-year Ph.D.
